Holotranscobalamin: Not Ready for Prime Time
Author:
Open Access
- 1 March 2012
- journal article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 58 (3) , 643-645
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- A review of the clinical presentation, natural history and inheritance of variegate porphyria: its implausibility as the source of the ‘Royal Malady’Journal of Clinical Pathology, 2011
- Biomarkers of cobalamin (vitamin B-12) status in the epidemiologic setting: a critical overview of context, applications, and performance characteristics of cobalamin, methylmalonic acid, and holotranscobalamin IIThe American Journal of Clinical Nutrition, 2011
- Diagnostic Accuracy of Holotranscobalamin, Methylmalonic Acid, Serum Cobalamin, and Other Indicators of Tissue Vitamin B12 Status in the ElderlyClinical Chemistry, 2011
- Attenuated variants of Lesch-Nyhan disease: the case of King James VI/IBrain, 2010
- The madness of King George III: a psychiatric re-assessmentHistory of Psychiatry: Madness, Science, Culture, 2010
- The blindness, deafness and madness of King George III: psychiatric interactionsJournal of the Royal College of Physicians of Edinburgh, 2010
- Measuring and Interpreting Holo-Transcobalamin (Holo-Transcobalamin II)Clinical Chemistry, 2002
- Increased Plasma Methylmalonic Acid Level Does Not Predict Clinical Manifestations of Vitamin B12 DeficiencyArchives of internal medicine (1960), 2001